Pda Technical Report 27 Pdf

Historically, a leak diameter of approximately 0.1 to 0.3 micrometers was viewed as the threshold for microbial ingress under specific capillary conditions.

. It is a foundational guidance document for the pharmaceutical industry, specifically focusing on: Parenteral Drug Association Container Closure Integrity (CCI):

Ensuring that a package remains an effective barrier against microbial contamination throughout its shelf life. Lifecycle Management: pda technical report 27 pdf

(A method for packages sealed under vacuum)

According to the report's structure, it addresses the following critical phases of packaging integrity: Integrity Assurance: Historically, a leak diameter of approximately 0

In the pharmaceutical industry, a "Container Closure System" (CCS) is the sum of packaging components that protect the drug product. If this system fails (e.g., a crack in a vial, a loose syringe plunger, or a faulty blister pack), the product is at risk of contamination, sterility loss, or degradation. TR 27 outlines the lifecycle approach to ensuring these systems remain integral from manufacturing through the product’s shelf life.

It outlines exactly what constitutes "integrity" and provides guidance on setting appropriate leak rate specifications. Lifecycle Management: (A method for packages sealed under

Criteria for choosing appropriate testing technologies based on sensitivity and product requirements. Microbial Integrity: